DRG 272: Does it provide adequate Burn Center reimbursement for the care of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis?

Journal of Burn Care and Research

Volumn 28, Issue 5, 2007, Pages 669-674

  Kagan, Richard J ^a,e   Edelman, Linda ^b   Solem, Lynn ^c   Saffle, Jeffrey R ^b   Gamelli, Richard ^d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c REGIONS HOSPITAL   (United States)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

^e SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HEALTH CARE UTILIZATION; HOSPITAL CHARGE; HOSPITAL COST; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MEDICARE; MORTALITY; PATIENT CARE; REIMBURSEMENT; STEVENS JOHNSON SYNDROME; TIME SERIES ANALYSIS; TOXIC EPIDERMAL NECROLYSIS;

BURN UNITS; BURNS; ECONOMICS, HOSPITAL; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MEDICARE; MIDDLE AGED; REGISTRIES; STEVENS-JOHNSON SYNDROME; UNITED STATES;

EID: 34548852579     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0B013E318148C8AC     Document Type: Article

References (10)

1. Hart AC, Hopkins CA, eds. 2003 International Classification of Diseases, 9th Revision, Clinical Modification. 6th edition. Salt Lake City, UT: Ingenix; 2002.
2. Schmidt K, Worthington D, eds. DRG Guidebook: A Comprehensive Resource to the DRG Classification System 2002. 18th edition. Salt Lake City, UT: Ingenix Publishing Group; 2001.
3. Kelemen JJ, Cioffi WG, McManus WF, et al. Burn center care for patients with toxic epidermal necrolysis. J Am Coll Surg 1995;180:273-8.
4. Herndon DN. Toxic epidermal necrolysis: a systemic and dermatologic disorder best treated with standard treatment protocols in burn intensive care units without the prolonged use of corticosteroids. J Am Coll Surg 1995;180:340-2.
5. Heimbach DM, Engrav LH, Marvin JA, et al. Toxic epidermal necrolysis: a step forward in treatment. JAMA 1987;257:2171-5
6. Palmieri TL, Greenhalgh DG, Saffle JR, et al. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century. J Burn Care Rehabil 2002;23:87-96.
7. Roujeau JC. The spectrum of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a clinical classification. J Invest Dermatol 1994;102:28S-30S.
8. Potts LH, Wayne JB, Dimick AR, et al. Comparison of variances in charges, costs, and length of stay explained by DRGs and severity of illness index in thermally injured patients. Proc Am Burn Assoc 1985;17:78.
9. Warden GD, Saffle JR, Kravitz M. Potential DRG reimbursement vs. actual cost for burn care, I: patients with burns of less than 25% TBSA. J Burn Care Rehabil 1986;7:45-51.
10. Jordan MH, Lewis MS, Jeng JG, et al. Treatment of toxic epidermal necrolysis by burn units: another market or another threat? J Burn Care Rehabil 1991;12:579-81.